ProCE Banner Activity

Managing AEs With Oral SERDs for Patients With HR+/HER2- Metastatic Breast Cancer

Slideset

Download these slides from a live satellite symposium at the San Antonio Breast Cancer Symposium covering strategies for the management of oral SERD-related AEs in patients with HR-positive/HER2-negative metastatic breast cancer.

Released: November 15, 2024

Expiration: November 14, 2025

Share

Faculty

Laura M. Spring

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Lilly

AstraZeneca

Lilly